IRONWOOD PHARMACEUTICALS, INC. Payments for (Proceeds from) Tenant Allowance
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Payments for (Proceeds from) Tenant Allowance of $22.90 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromTenantAllowance · last filed 2016-02-19
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2012-12-31 was $900.00K.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2012-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2012-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2012-03-31 was $16.60M.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for fiscal 2015 was $22.90M, a 0.00% change from fiscal 2014.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for fiscal 2014 was $22.90M, a 30.86% increase from fiscal 2013.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for fiscal 2013 was $17.50M, a 0.00% change from fiscal 2012.
- IRONWOOD PHARMACEUTICALS, INC. payments for (proceeds from) tenant allowance for fiscal 2012 was $17.50M, a 10.06% increase from fiscal 2011.
| Period end | Payments for (Proceeds from) Tenant Allowance 3 month | Payments for (Proceeds from) Tenant Allowance 6 month | Payments for (Proceeds from) Tenant Allowance 9 month | Payments for (Proceeds from) Tenant Allowance 12 month |
|---|---|---|---|---|
| 2015-12-31 | $22.90M 10-K · filed 2016-02-19 | |||
| 2014-12-31 | $22.90M 10-K · filed 2015-02-18 | |||
| 2013-12-31 | $17.50M 10-K · filed 2014-02-07 | |||
| 2012-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $900.00K derived: sum of 2 quarters · filed 2013-02-21 | $900.00K derived: sum of 3 quarters · filed 2013-02-21 | $17.50M 10-K · filed 2013-02-21 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $16.60M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $16.60M 10-Q · filed 2012-08-07 | ||
| 2012-03-31 | $16.60M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $15.90M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |